Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News BioSig Technologies Inc. BSGM

BioSig Technologies Inc is a commercial stage medical device company. It is developing a proprietary technology platform to minimize noise and artifacts from cardiac recordings during electrophysiology studies and ablation.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:BSGM)

Fundamentals Snapshot (NDAQ:BSGM)

Opinion & Analysis (NDAQ:BSGM)

No current opinion is available.

Bullboard Posts (NDAQ:BSGM)

RE:BioSig to Participate in Benzinga All Access Event: Dec 14th

The presentation will be broadcast live at 9:40 am EST on Tuesday, December 14th, 2021. To watch the live event, please click...
Adwari - December 15, 2021

BioSig to Participate in Benzinga All Access Event: Dec 14th

" I look forward to sharing some of those highlights including first commercial sales, the completion of approximately 1800 patient...
Adwari - December 15, 2021

Seeking Alpha Poured Cold Water on it

BioSig makes record gains after exceeding procedural target for 2021 BioSig Technologies (BSGM +19.6%) has climbed to post the...
Adwari - November 2, 2021

RE:Laidlaw Securities $17 Target

http://player.fm/series/proactive-interviews-for-investors/biosig-technologies-taps-medical-device-industry-executive-james-barry-as...
0checker - September 23, 2021

Laidlaw Securities $17 Target

Doubling from current lavels could still be a possibility . Read this report https://pennystocks.news/stock-soars-on-covid-cocktail...
elotto777 - June 1, 2020

$17 Target Laidlaw

This company has come alive - Doubling fromhttps://pennystocks.news/stock-soars-on-covid-cocktail-bsgm-nasdaq-bsgm-262-2850-8-6471/ ...
elotto777 - June 1, 2020